We test whether H. pylori cagI and cagY genopositive rate or amino acid polymorphisms correlate to clinical outcomes, and whether cagI and cagY amino acid polymorphisms increase integrin β1 activation to translocate CagA under adverse pH conditions. Methods: We performed PCR and sequencing to screen cagI

and cagY locus of 131 strains and to predict the amino acid sequences. A panel of cagI mutants was generated from gastric cancer (GCA) isolate (Hp1033) to co-culture with AGS cells at pH7.4 & 5.4. The protein levels of active integrin β1 and phosphorylated CagA were determined by western blot. Results: The prevalence rates of H. pylori cagI and cagY were nearly 100%. H. pylori isolates of GCA patients had a higher rate Maraviroc solubility dmso of CagI polymorphisms as N125 than those of non-GCA patients (90.9% vs. 68.8%, p = 0.037). CagI-N125 had 4.5-fold risk of GCA as compared to K125 (95% CI: 1.0–20.5). CagY polymorphisms didn’t correlate with GCA, but CagY as I1752 had a 3.7-fold increased risk (95% CI: 1.2–11.4, p = 0.033) to have gastric ulcer. In co-cultured with AGS cells, CagI-N125 strain had higher active integrin β1 at pH5.4 (p < 0.05), but not at pH7.4 (p > 0.05), and showed marginally higher phosphorylated CagA (p = 0.1) than N125K replacement mutant. Conclusion: H.

pylori with CagI-N125 correlate with a higher GCA risk, and can activate more integrin β1 at low pH to facilitate CagA translocation for gastric carcinogenesis. Key Word(s): 1. H. pylori; 2. CagI; 3. integrin β1; 4. gastric cancer; Presenting buy Adriamycin Author: XUEFANG HUANG Additional Authors: NANA YANG, SANPING XU Corresponding Author: SANPING XU Affiliations: Union Hospital, Tongji Medical College Objective: HP-NAP is one of the virulence factors secreted by Helicobacter pylori. It was found that HP-NAP, as a ligand of TLR2, could promote INF-γ-producing Th1 immune response, and at the same time the activation of TLR2 may resulted in the Th17

cell differentiation PIK3C2G from helper T cell, inhabiting Treg cell function. Therefore, we established a mouse model of gastric cancer to explore the pole of HP-NAP on growth of gastric cancer by regulating the immune balance of Th17/Treg cells. Methods: A total of 18 SPF male 615 mice were randomly divided into healthy control group, gastric cancer group, the intervention group. Both gastric cancer group and intervention group were injected subcutaneously of 7*106 MFC cells 200ul in the right lower limb roots in mice. Mice of intervention group were respectively treated with peritumoral injection of 40 ug/100 ul/dose of HP-NAP 150 ul on days 0, 3, 6, 9, 12; the mice of gastric cancer group were given with peritumoral injection of 150 ul sterile PBS at the same time. All of mice were killed at day 14 and tumours were excised and analysed. First, To assess the growth of tumor, we measured the size of volume of tumours and detected the expression of vascular endothelium growth factor (VEGF) mRNA level.